(Q43750659)

26 November 2017

title

Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder (English)

1 reference

26 November 2017

0 references

1 reference

1 reference

Meador-Woodruff JH

1 reference

26 November 2017

Hogg AJ Jr

series ordinal

1 reference

26 November 2017

Smith RE

series ordinal

1 reference

26 November 2017

publication date

1 July 2001

1 reference

26 November 2017

published in

Brain Research Bulletin

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

631-640

1 reference

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Immunoautoradiographic evidence for a loss of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Properties of [3H]AMPA Binding in Postmortem Human Brain from Psychotic Subjects and Controls: Increases in Caudate Nucleus Associated with Suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Recombinant human NMDA homomeric NR1 receptors expressed in mammalian cells form a high-affinity glycine antagonist binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Cloned glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Amelioration of negative symptoms in schizophrenia by glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Abnormal kainate receptor expression in prefrontal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Glutamate receptor expression in schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Molecular diversity of glutamate receptors and implications for brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

RNA editing of human kainate receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

RNA Editing of the Glutamate Receptor Subunits GluR2 and GluR6 in Human Brain Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Block of the N-methyl-d-aspartate receptor by phenycyclidine-like drugs is influenced by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

D-cycloserine adjuvant therapy to molindone in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Rat GluR7 and a carboxy-terminal splice variant, GluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

The role of RNA editing in controlling glutamate receptor channel properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2801%2900523-8

7 January 2021

10.1016/S0361-9230(01)00523-8

Identifiers

DOI

1 reference

26 November 2017

1 reference